Omega-3s Linked to Reduction of Arterial Blood Clots
Cardiovascular disease (CD) is an increasingly problematic ailment in the US, effecting thousands of people yearly. A recent study suggests that supplementation with omega-3 fatty-acids may reduce the risk of arterial blood clots by reducing platelet aggregation in individuals with cardiovascular disease.
Platelet aggregation is the process by which platelets adhere to each other to form a platelet plug over damaged blood vessels. Excessive platelet aggregation can result in blood clots forming in the heart or blood vessels.
The study included 16 individuals with CD and 40 healthy participants. Over the course of four weeks, all of the participants took a supplement of 640 mg omega-3s, consisting of 520 mg DHA and 120 EPA.
The greatest reduction in platelet aggregation was seen in the healthy subjects. However, reductions were also noted in the CD group, suggesting that a higher dose of omega-3 supplementation may be advisable for individuals with cardiovascular disease.
The study was conducted by researchers at the University of South Wales in Australia. It was published in the February 2013 issue of Seminars in Thrombosis and Hemostasis.
Omega-3s have also been shown to improve inflammation, mood, joint mobility, age related macular degeneration, and the immune system.
Because omega-3 fatty-acids are not found naturally in the human body, it is especially important to make sure that they are a part of your daily diet. Oily, dark fish such as tuna and salmon are high in DHA and EPA omega-3s. You can also take a high quality supplement that has been tested for purity and potency.